| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |